MARLBOROUGH, Mass.,
May 15, 2019 /PRNewswire/
-- Boston Scientific Corporation (NYSE: BSX) will participate
in Bernstein's 35th Annual Strategic Decisions
Conference on Wednesday, May 29, 2019
in New York City.
Mike Mahoney, chairman and chief
executive officer, and Susie Lisa,
vice president, Investor Relations, will participate in a 50-minute
question-and-answer session with the host analyst beginning at
approximately 8:00 a.m. EDT. A
live webcast of the question-and-answer session will be available
on the Investor Relations section of the Boston Scientific website
at investors.bostonscientific.com.
A replay of the webcast will be accessible at
investors.bostonscientific.com beginning approximately one
hour following the completion of the event.
About Boston Scientific
Boston Scientific transforms
lives through innovative medical solutions that improve the health
of patients around the world. As a global medical technology
leader for 40 years, we advance science for life by providing a
broad range of high performance solutions that address unmet
patient needs and reduce the cost of healthcare. For more
information, visit www.bostonscientific.com and connect on Twitter
and Facebook.
CONTACTS
|
|
Media:
|
Investors:
|
Katie
Schur
|
Susie Lisa,
CFA
|
508-683-5574
(office)
|
508- 683-5565
(office)
|
Media
Relations
|
Investor
Relations
|
Boston Scientific
Corporation
|
Boston Scientific
Corporation
|
Katie.Schur@bsci.com
|
BSXInvestorRelations@bsci.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-bernsteins-35th-annual-strategic-decisions-conference-300850663.html
SOURCE Boston Scientific Corporation